Genicore Biotech CO., LTD. will be participating in the 2025 Taiwan Healthcare+ Expo held at the Nangang Exhibition Center, Hall 1, 4th Floor, from December 4th to December 7th, 2025.

Recent research demonstrates that aptamer-DNAzyme-based metal-nucleic acid frameworks (MNFs) represent a significant advancement in targeted gastric cancer therapy, offering improved stability, synthesis efficiency, and tumor specificity compared to earlier nanomaterial approaches.

Genicore Biotech will be participating in Bio Asia-Taiwan 2025 from July 24 to 27, 2025, at Booth M1129, 4F, Nangang Exhibition Center Hall 1.